Incyte is a drug discovery and development company which hopes to build a proprietary product pipeline of novel small molecule drugs. read more
Hervé Hoppenot Incyte CEO Rating
Hervé Hoppenot Incyte CEO Rating
Incyte's CEO, Hervé Hoppenot, has 19 employee ratings and a score of 83/100, placing them in the Top 5% of similar size companies on Comparably with 501-1,000 Employees.
Where This Score Ranks Incyte's CEO Rating
- TOP5%
In the Top 5% of 1832 Similar Sized Companies on Comparably
- 1st
1st place versus 3 competitors rated on Comparably
81
Jan
82
Mar
80
Apr
81
May
82
Aug
A+83 / 100
Jan
Incyte CEO Hervé Hoppenot Bio
Hervé Hoppenot serves as the CEO / President of Incyte.
Not Enough Ratings To Show Who Ranks CEO Rating the Lowest
Anonymously rate my experience at IncyteIncyte CEO Hervé Hoppenot At a Glance
The CEO score provides an understanding of how employees feel about the CEO’s leadership style and effectiveness at Incyte.
Based on 19 ratings, Hervé Hoppenot ranks right above Karyopharm Therapeutics' CEO, Richard Paulson.
Incyte's CEO is highly regarded by Caucasian employees and Female employees. Overall, the CEO score has remained stable over the last 90 days.
Incyte CEO Hervé Hoppenot Rating Trendline
- Incyte83
- Similar Size on Comparably
Incyte's CEO Rating Rank Against Similar Sized Companies on Comparably
TOP
5%
Incyte ranks in the Top 5% of other companies on Comparably with 501-1,000 Employees for CEO Rating Score.
Anonymously Ask Incyte Any Question
Are You an Employee at Incyte?
Anonymously Rate Your Experience & Make Work BetterSee other culture dimensions at Incyte
×